A promising solution to HLB is advancing to Phase 2 field trials following research by a Central State University scientist in Ohio. Anthony Arment, a molecular biologist and professor of biology at Central State University, played a key role in early research and ongoing consultation for the project. Pop Test Oncology LLC, operating as Palisades Therapeutics, recently announced that its …
